Showing results (61-70 of 99) with videos related to
Sort By:
Pageof 10
Plos One|August 24, 2010
Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor HCinzia Scambi, Valentina La Verde, Lucia De Franceschi, et al.Plos One|February 7, 2015
The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating studyCinzia Scambi, Sara Ugolini, T Sakari Jokiranta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi surveyCorrado Tarella, Manuela Zanni, Michele Magni, et al.Blood|January 5, 2002
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignanciesPaolo Corradini, Corrado Tarella, Attilio Olivieri, et al.Nature Immunology|April 28, 2022
CD66b<sup>-</sup>CD64<sup>dim</sup>CD115<sup>-</sup> cells in the human bone marrow represent neutrophil-committed progenitorsFederica Calzetti, Giulia Finotti, Nicola Tamassia, et al.Blood|March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availabilityBarbara Sarina, Luca Castagna, Lucia Farina, et al.Bone Marrow Transplantation|April 30, 2020
Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter studyNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.Bone Marrow Transplantation|May 5, 2022
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter seriesMichele Wieczorek, Sara Mariotto, Sergio Ferrari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphomaCorrado Tarella, Roberto Passera, Michele Magni, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2021
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantationNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.Pageof 10